Peregrine Pharmaceuticals' Anti-PS Technology Platform To Be Discussed At AIDS Vaccine 2008 Conference Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) a clinical stage biopharmaceutical company developing monoclonal antibodies for cancer and serious viral infections, reported the company's anti-phosphatidylserine (anti-PS) technology platform will be discussed in scientific sessions at the AIDS Vaccine 2008 conference in Cape Town, South Africa.
Source: www.medicalnewstoday.com
# posted by Network @ 7:00 AM
